Modified GTX as Second-Line Chemotherapy in Advanced Pancreatic Cancer.
作者信息
Dbouk Haifa, Ajouz Hana, Shamseddine Ali, Mukherji Deborah, O'Reilly Eileen M, Haydar Ali, Kelsen David, Naghy Mohamed, Eloubeidi Mohamed, Geara Fadi, Saltz Leonard, Abou-Alfa Ghassan K
机构信息
American University of Beirut Beirut, Lebanon.
出版信息
Gastrointest Cancer Res. 2013 Jul;6(4):115-7.
Abstract
摘要
相似文献
1
Modified GTX as Second-Line Chemotherapy in Advanced Pancreatic Cancer.改良吉西他滨作为晚期胰腺癌的二线化疗方案
Gastrointest Cancer Res. 2013 Jul;6(4):115-7.
2
Clinically meaningful responses to sequential gemcitabine-based chemotherapy regimens in a patient with metastatic pancreatic cancer.一名转移性胰腺癌患者对基于吉西他滨的序贯化疗方案产生了具有临床意义的反应。
Case Rep Oncol. 2013 Jan;6(1):72-7. doi: 10.1159/000346836. Epub 2013 Jan 29.
3
4
Selective estrogen receptor alpha agonist GTx-758 decreases testosterone with reduced side effects of androgen deprivation therapy in men with advanced prostate cancer.选择性雌激素受体 α 激动剂 GTx-758 可降低晚期前列腺癌男性的睾酮水平，减少雄激素剥夺治疗的副作用。
Eur Urol. 2015 Feb;67(2):334-41. doi: 10.1016/j.eururo.2014.06.011. Epub 2014 Jun 24.
5
The prognostic impact of tumour location and first-line chemotherapy regimen in locally advanced pancreatic cancer.局部晚期胰腺癌中肿瘤位置和一线化疗方案的预后影响。
Jpn J Clin Oncol. 2021 Apr 30;51(5):728-736. doi: 10.1093/jjco/hyab014.
6
FOLFIRINOX as second-line chemotherapy for advanced pancreatic cancer: A subset analysis of data from a nationwide multicenter observational study in Japan.FOLFIRINOX 作为晚期胰腺癌二线化疗：来自日本全国多中心观察性研究数据的亚组分析。
Pancreatology. 2020 Oct;20(7):1519-1525. doi: 10.1016/j.pan.2020.07.006. Epub 2020 Jul 28.
7
Skeletal Muscle Mass Predicts Poor Prognosis in Patients with Advanced Pancreatic Cancer Undergoing Second-Line FOLFIRINOX Chemotherapy.骨骼肌量预测二线 FOLFIRINOX 化疗的晚期胰腺癌患者预后不良。
Nutr Cancer. 2019;71(7):1100-1107. doi: 10.1080/01635581.2019.1597906. Epub 2019 Apr 7.
8
[Second-line chemotherapy for advanced pancreatic cancer].
Gan To Kagaku Ryoho. 2015 Apr;42(4):403-7.
9
Kinetics of grayanotoxin evoked modification of sodium channels in squid giant axons.冈田酸诱发鱿鱼巨大轴突钠通道修饰的动力学
Pflugers Arch. 1997 Feb;433(4):403-12.
10
Impact of high-dose granulocyte transfusions in patients with cancer with candidemia: retrospective case-control analysis of 491 episodes of Candida species bloodstream infections.高剂量粒细胞输注对念珠菌血症癌症患者的影响：491例念珠菌属血流感染病例的回顾性病例对照分析
Cancer. 2004 Dec 15;101(12):2859-65. doi: 10.1002/cncr.20710.
本文引用的文献
1
Gemcitabine and cisplatin combined with regional hyperthermia as second-line treatment in patients with gemcitabine-refractory advanced pancreatic cancer.吉西他滨和顺铂联合区域热疗二线治疗吉西他滨耐药的晚期胰腺癌。
Int J Hyperthermia. 2013;29(1):8-16. doi: 10.3109/02656736.2012.740764. Epub 2012 Dec 17.
2
Adjuvant therapy for pancreas adenocarcinoma.胰腺腺癌的辅助治疗。
J Surg Oncol. 2013 Jan;107(1):78-85. doi: 10.1002/jso.23230. Epub 2012 Aug 6.
3
Phase II study of palliative S-1 in combination with cisplatin as second-line chemotherapy for gemcitabine-refractory pancreatic cancer patients.替吉奥联合顺铂作为吉西他滨耐药胰腺癌患者二线化疗的姑息性治疗II期研究。
Oncol Lett. 2012 Jun;3(6):1314-1318. doi: 10.3892/ol.2012.637. Epub 2012 Mar 8.
4
FOLFIRI as second-line chemotherapy for advanced pancreatic cancer: a GISCAD multicenter phase II study.FOLFIRI 二线治疗晚期胰腺癌的疗效：一项 GISCAD 多中心 II 期研究。
Cancer Chemother Pharmacol. 2012 Jun;69(6):1641-5. doi: 10.1007/s00280-012-1875-1. Epub 2012 May 11.
5
A phase II trial of nab-Paclitaxel as second-line therapy in patients with advanced pancreatic cancer.一项纳武利尤单抗二线治疗晚期胰腺癌的 II 期临床试验。
Am J Clin Oncol. 2013 Apr;36(2):151-6. doi: 10.1097/COC.0b013e3182436e8c.
6
The use of GTX as second-line and later chemotherapy for metastatic pancreatic cancer: a retrospective analysis.GTX 作为转移性胰腺癌二线及以后化疗的应用：回顾性分析。
Cancer Chemother Pharmacol. 2012 Feb;69(2):425-30. doi: 10.1007/s00280-011-1705-x. Epub 2011 Aug 18.
7
A multicenter analysis of GTX chemotherapy in patients with locally advanced and metastatic pancreatic adenocarcinoma.GTX 化疗治疗局部晚期和转移性胰腺腺癌的多中心分析。
Cancer Chemother Pharmacol. 2012 Feb;69(2):415-24. doi: 10.1007/s00280-011-1704-y. Epub 2011 Jul 29.
8
Detection of pancreatic carcinoma and liver metastases with gadoxetic acid-enhanced MR imaging: comparison with contrast-enhanced multi-detector row CT.钆塞酸增强磁共振成像检测胰腺癌和肝转移瘤：与增强多排 CT 的比较。
Radiology. 2011 Aug;260(2):446-53. doi: 10.1148/radiol.11103548. Epub 2011 Jun 21.
9
Best supportive care (BSC) versus oxaliplatin, folinic acid and 5-fluorouracil (OFF) plus BSC in patients for second-line advanced pancreatic cancer: a phase III-study from the German CONKO-study group.二线治疗晚期胰腺癌患者的最佳支持治疗（BSC）对比奥沙利铂、亚叶酸钙和 5-氟尿嘧啶（OFF）加 BSC：德国 CONKO 研究组的 III 期研究。
Eur J Cancer. 2011 Jul;47(11):1676-81. doi: 10.1016/j.ejca.2011.04.011. Epub 2011 May 10.
10
FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer.FOLFIRINOX 对比吉西他滨治疗转移性胰腺癌。
N Engl J Med. 2011 May 12;364(19):1817-25. doi: 10.1056/NEJMoa1011923.
Zotero 插件